Occurrence of medical co-morbidity in mild cognitive impairment: implications for generalisation of MCI research
Background: diagnosis of mild cognitive impairment (MCI) typically excludes individuals with medical co-morbidity. Interest in MCI screening raises the questions of what are the best criteria to identify a representative sample and what factors are associated with MCI progression to dementia.
Main Authors: | Stephan, Blossom C. M., Brayne, Carol, Savva, George M., Matthews, Fiona E. |
---|---|
Format: | Online |
Language: | English |
Published: |
Oxford University Press
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290328/ |
Similar Items
-
Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review
by: Christa Maree Stephan, Blossom, et al.
Published: (2013) -
Operationalisation of Mild Cognitive Impairment: A Graphical Approach
by: Matthews, Fiona E, et al.
Published: (2007) -
Brain Dynamics of Mild Cognitive Impairment (MCI) from EEG
Features
by: Norsiah, Fauzan, et al.
Published: (2015) -
Dysfunctional Incidental Olfaction in Mild Cognitive Impairment (MCI): An Electroencephalography (EEG) Study
by: Walla, Peter, et al.
Published: (2011) -
Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI)
by: Ann J. Jones, et al.
Published: (2017-06-01)